Literature DB >> 15899242

Histamine H(1) and H(3) receptors in the rat thalamus and their modulation after systemic kainic acid administration.

Congyu Jin1, Minnamaija Lintunen, Pertti Panula.   

Abstract

In rat thalamus, histamine H(1) receptor and isoforms of H(3) receptor were expressed predominantly in the midline and intralaminar areas. Correspondingly, higher H(1) and H(3) receptor binding was also detected in these areas. All isoforms of H(3) receptor were expressed in several thalamic nuclei, but there were minor differences between their expression patterns. H(1) mRNA expression was high in the ventral thalamus, but the H(1) binding level was low in these areas. Since increased brain histamine appears to have an antiepileptic effect through the H(1) receptor activity, kainic acid (KA)-induced status epilepticus in rat was used to study modulation of H(1) and H(3) receptors in the thalamus following seizures. After systemic KA administration, transient decreases in mRNA expression of H(1) receptor and H(3) receptor isoforms with full-length third intracellular loops were seen in the midline areas and the H(1) receptor mRNA expression also decreased in the ventral thalamus. After 1 week, a robust increase in mRNA expression of H(3) receptor isoforms with a full-length third intracellular loop was found in the ventral posterior, posterior, and geniculate nuclei. The changes indicate a modulatory role of H(3) receptor in the sensory and motor relays, and might be involved in possible neuroprotective and compensatory mechanisms after KA administration. However, short-term increases in the H(3) receptor binding appeared earlier (72 h) than the increases of H(3) mRNA expression (1-4 w). The elevations in H(3) binding were evident in the intralaminar area, laterodorsal, lateral posterior, posterior and geniculate nuclei, and were likely to be related to the cortical and subcortical inputs to thalamus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899242     DOI: 10.1016/j.expneurol.2005.01.012

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

1.  Role of the thalamic submedius nucleus histamine H1 and H 2 and opioid receptors in modulation of formalin-induced orofacial pain in rats.

Authors:  Amir Erfanparast; Esmaeal Tamaddonfard; Mina Taati; Milad Dabaghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-16       Impact factor: 3.000

2.  H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway.

Authors:  Heather Francis; Antonio Franchitto; Yoshiyuki Ueno; Shannon Glaser; Sharon DeMorrow; Julie Venter; Eugenio Gaudio; Domenico Alvaro; Giammarco Fava; Marco Marzioni; Bradley Vaculin; Gianfranco Alpini
Journal:  Lab Invest       Date:  2007-03-05       Impact factor: 5.662

Review 3.  Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.

Authors:  M Bhowmik; R Khanam; D Vohora
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 4.  The histaminergic network in the brain: basic organization and role in disease.

Authors:  Pertti Panula; Saara Nuutinen
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

Review 5.  Intrinsic properties and neuropharmacology of midline paraventricular thalamic nucleus neurons.

Authors:  Miloslav Kolaj; Li Zhang; Michael L H J Hermes; Leo P Renaud
Journal:  Front Behav Neurosci       Date:  2014-04-17       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.